Exercise News and Research

Latest Exercise News and Research

Victoza produces greater reductions in A1C, FPG and body weight than Januvia: Study

Yesterday, The Lancet published online the results of the first study comparing the once-daily human GLP-1 analog, Victoza (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia. The 26-week trial showed that Victoza produced significantly greater reductions in A1C, fasting plasma glucose, and body weight than Januvia, with similar or better overall treatment satisfaction.

24 Apr 2010

Broadspire, Medcor partner to provide direct immediate post-injury treatment for employees

Broadspire, a Crawford Company and leading third party administrator of workers compensation claims, liability claims and medical management services, and Medcor, a leading injury triage provider, are partnering to implement services to more effectively direct immediate post-injury treatment for employees.

24 Apr 2010

Arcadia Capital Advisors MD commences all-cash tender offer for CPEX Pharmaceuticals

Arcadia Capital Advisors Managing Director Richard Rofé announced today that he has commenced a $16.00 per share all-cash tender offer for CPEX Pharmaceuticals, Inc. through RSR Acquisition Co., a wholly-owned subsidiary of Shelter Bay Holdings, LLC.

23 Apr 2010

Cipher Pharmaceuticals' first-quarter total revenue up 52%

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three months ended March 31, 2010.

23 Apr 2010

More tips to protect lungs on elevated-ozone days

It's a harmless-looking pale blue gas, a relative of the oxygen molecule that sustains life. In the upper atmosphere, a layer of it protects us from the sun's harmful rays.

23 Apr 2010

Micromedex clinical decision support and CareNotes content to be integrated within M2 HCIS

Micromedex clinical decision support and CareNotes® patient education content from Thomson Reuters will be integrated within the M2 Health Care Information System (HCIS).

23 Apr 2010

Medical Properties Trust closes underwritten public offering of common stock

Medical Properties Trust, Inc. announced today that it closed the sale of its previously announced underwritten public offering of shares of common stock, which included 26 million shares of common stock issued on April 20, 2010 and 3.9 million shares of common stock issued on April 22, 2010 pursuant to the exercise in full of the underwriters' over-allotment option.

23 Apr 2010

Nile Therapeutics prices underwritten public offering of common stock

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the pricing of its previously announced underwritten public offering of 6,500,000 units of its securities at a public offering price of $0.70 per unit. Each unit consists of one share of Nile common stock and 0.30 warrants to purchase common stock.

23 Apr 2010

Physical exercise and computer use may help protect against mild cognitive impairment: Mayo Clinic

A new Mayo Clinic study found that physical exercise and computer use may help protect against mild cognitive impairment, a disorder of the brain that affects nerve cells involved in thinking abilities.

23 Apr 2010

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New Drug Application (NDA) submission for BYDUREON™ (exenatide for extended-release injectable suspension).

23 Apr 2010

Actelion Pharmaceuticals launches Epoprostenol for Injection for treatment of primary pulmonary hypertension

Actelion Pharmaceuticals US, Inc. today announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and pulmonary hypertension associated with scleroderma spectrum of disease in NYHA Class III and Class IV patients.

22 Apr 2010

New campaign highlights dangers of carrying excess weight around waist

Cancer Research UK has joined forces with the British Heart Foundation and Diabetes UK to launch a new campaign to raise awareness of the dangers of carrying excess weight around the waist.

22 Apr 2010

ISHLT announces new guidelines for heart transplant recipients

The International Society for Heart and Lung Transplantation (ISHLT) today announces new guidelines to standardize care for heart transplant patients worldwide. The guidelines demonstrate a united effort to decrease complications, improve outcomes and increase patient survival rates among heart transplant recipients. The guidelines will be presented during today's symposium The ISHLT Guidelines for Heart Transplant Recipients: Towards an International Consensus at the ISHLT 30th Annual Meeting and Scientific Sessions at the Hilton Chicago.

22 Apr 2010

Cybex International defends intellectual property rights related to patented Plate Loaded Leg Press

Cybex International, Inc., a leading manufacturer of premium exercise equipment, announced today that it has decisively responded to infringements of its intellectual property rights related to its patented Plate Loaded Leg Press and the company's pending patent applications for the Bravo Functional Trainer.

22 Apr 2010

New studies on cancer prevention presented at 101st AACR Annual Meeting 2010

Interest in cancer prevention is increasing as scientists continue to learn new information and confirm what was already suspected.

22 Apr 2010

Children born very early have abnormal lung function: U.K. researchers

More than half of children who were born very early—at 25 weeks or less (normal gestation is around 40 weeks)— have abnormal lung function and are twice as likely as their full-term peers to have a diagnosis of asthma, according to U.K. researchers, who followed a national cohort of extremely preterm infants to age 11.

22 Apr 2010

NPS Pharmaceuticals closes public offering of common stock shares

NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 10,350,000 shares of its common stock, including 1,350,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. All of the shares were offered by the Company. Net proceeds were approximately $53.3 million after deducting underwriting discounts and commissions, and estimated offering expenses. Canaccord Adams acted as sole book-running manager and Needham & Company, LLC acted as co-manager for the offering.

22 Apr 2010

2008 Physical Activity Guidelines for Americans interpreted for practical use by health care professionals

The first formal U.S. government recommendations on physical activity, the Physical Activity Guidelines for Americans, were published in 2008. Now, those guidelines have been interpreted for practical use by health care professionals in the American Journal of Lifestyle Medicine, published by SAGE.

22 Apr 2010

Positive results from initial clinical trial of ClariVein catheter

Results from the initial clinical trial of the ClariVein® catheter, used in a new minimally invasive treatment for varicose veins, have been announced. The device combines mechanical and chemical modalities to accomplish vein treatment in an in-office setting.

22 Apr 2010

Abbott acquires Facet Biotech

Abbott has completed its acquisition of Facet Biotech Corporation, strengthening its pharmaceutical pipeline in immunology and oncology.

22 Apr 2010

Exercise News and Research

Latest Exercise News and Research

Victoza produces greater reductions in A1C, FPG and body weight than Januvia: Study

Broadspire, Medcor partner to provide direct immediate post-injury treatment for employees

Arcadia Capital Advisors MD commences all-cash tender offer for CPEX Pharmaceuticals

Cipher Pharmaceuticals' first-quarter total revenue up 52%

More tips to protect lungs on elevated-ozone days

Micromedex clinical decision support and CareNotes content to be integrated within M2 HCIS

Medical Properties Trust closes underwritten public offering of common stock

Nile Therapeutics prices underwritten public offering of common stock

Physical exercise and computer use may help protect against mild cognitive impairment: Mayo Clinic

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Actelion Pharmaceuticals launches Epoprostenol for Injection for treatment of primary pulmonary hypertension

New campaign highlights dangers of carrying excess weight around waist

ISHLT announces new guidelines for heart transplant recipients

Cybex International defends intellectual property rights related to patented Plate Loaded Leg Press

New studies on cancer prevention presented at 101st AACR Annual Meeting 2010

Children born very early have abnormal lung function: U.K. researchers

NPS Pharmaceuticals closes public offering of common stock shares

2008 Physical Activity Guidelines for Americans interpreted for practical use by health care professionals

Positive results from initial clinical trial of ClariVein catheter

Abbott acquires Facet Biotech

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exercise News and Research

Latest Exercise News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in